BLOOD 09-10

Embed Size (px)

Citation preview

  • 8/6/2019 BLOOD 09-10

    1/44

    BLOOD

  • 8/6/2019 BLOOD 09-10

    2/44

    food, water intake oxygen intake

    DIGESTIVE

    SYSTEM

    RESPIRATORY

    SYSTEM

    elimination ofcarbon dioxide

    nutrients,water,salts

    O2 CO2

    CIRCULATORYSYSTEM URINARYSYSTEM

    water,solutes

    elimination

    of foodresidues

    rapid transport to and

    from all living cells

    elimination of excess

    water, salts, wastes

    Functional Interconnections

  • 8/6/2019 BLOOD 09-10

    3/44

    lungs

    hearts right half hearts left half

    liver

    digestive tract

    kidneys

    skeletal muscle

    brain

    skin

    bone

    cardiac muscle

    all other regions

  • 8/6/2019 BLOOD 09-10

    4/44

    tonsils

    right lymphatic duct

    thymus gland

    thoracic duct

    spleen

    lymph vessels

    lymph nodes

    bone marrow

    The

    LymphaticSystem

  • 8/6/2019 BLOOD 09-10

    5/44

    Lymph Vascular System Fluid enters lymph

    capillaries

    Capillaries merge into

    lymph vessels Lymph vessels converge

    into ducts that funnel fluid

    into veins in the lower

    neck flaplike valve at tipof a lymph capillary

  • 8/6/2019 BLOOD 09-10

    6/44

    Fig. 31.18b

  • 8/6/2019 BLOOD 09-10

    7/44

    lymph trickles past organized arrays oflymphocytes within the lymph node

    valve (prevents backflow)

    lymph node(cross section)

  • 8/6/2019 BLOOD 09-10

    8/44

  • 8/6/2019 BLOOD 09-10

    9/44

    Components of Blood

    Blood

    6-8%of body

    weight

    Plasma portion (50-60% of total volume) Water Proteins Ions, sugars, lipids, amino acids,hormones, vitamins, dissolved gases

    Cellular portion (40-50% of total volume) White blood cells

    NeutrophilsLymphocytes

    MonocytesEosinophilsBasophils

    Red blood cells Platelets

  • 8/6/2019 BLOOD 09-10

    10/44

  • 8/6/2019 BLOOD 09-10

    11/44

  • 8/6/2019 BLOOD 09-10

    12/44

    Characteristics:

    10-12 m in diameter Nucleus: 2-5 lobes Granules: very fine pale lilac

    Function: phagocytosis

    Clinical significance:Increased:

    Bacterial infections Burns Stress Inflammation

    Decreased Radiation Certain drugs Vit B12 deficiency SLE

    NEUTROPHIL

  • 8/6/2019 BLOOD 09-10

    13/44

    Characteristics: 10-12 m in diameter

    Nucleus: 2-3 lobes Granules: large red-orange

    Functions:

    combats effects of histamine inallergic reactions phagocytizes Ag-Ab complexes destroys certain parasitic worms

    Clinical significanceIncreased:

    allergic reactions parasitic infections

    autoimmune disease adrenal insufficiency

    Decreased

    certain drugs stress

    Cushings syndrome

    EOSINOPHIL

  • 8/6/2019 BLOOD 09-10

    14/44

    Characteristics:

    8-10 m in diameter Nucleus: 2 lobes

    Granules: large deep blue-purple

    Function:- liberates heparin, histamine and

    serotonin in allergic reactions that

    intensify the overall inflammatory

    response

    Clinical significance

    Increased: some types of allergic responses

    leukemias

    cancers

    hyperthyroidism

    BASOPHIL

  • 8/6/2019 BLOOD 09-10

    15/44

    Characteristics:

    12-20 m in diameter nucleus: kidney-shaped or

    horseshoe-shaped

    cytoplasm: blue-gray with

    foamy appearance

    Function: phagocytosis

    Clinical significance

    Increased:

    certain viral or fungalinfections

    tuberculosis

    some leukemias

    chronic diseases

    MONOCYTE

  • 8/6/2019 BLOOD 09-10

    16/44

    Characteristics:

    small: 6-9 ; large : 10-14 m indiameter

    nucleus: round or slightly indented

    cytoplasm: sky blue in color; forms arim around the nucleus

    Function: mediates immuneresponses

    Clinical significance

    Increased: viral infections

    immune diseases

    some leukemias

    Decreased prolonged severe illness

    high steroid levels

    immunosuppression

    LYMPHOCYTE

  • 8/6/2019 BLOOD 09-10

    17/44

    Complete Blood AnalysisNormal Values:

    1.RBC count: about 5.4M/

    L in malesabout 4.8 M/L in females

    2. Hemoglobin 14-18 g/dl in adult males12-16 g/dl in adult females

    3. Hematocrit 38-46 (ave. 42) in females40-54 (ave. 47) in males

  • 8/6/2019 BLOOD 09-10

    18/44

    Clinical Significance:

    A. Increased in RBC count, Hgb and Hct

    1. Polycythemia

    2. CHD

    3. Hypoxia

    B. Decreased in RBC count, Hgb and Hct

    1. Hemorrhage

    2. Certain types of anemia

  • 8/6/2019 BLOOD 09-10

    19/44

  • 8/6/2019 BLOOD 09-10

    20/44

    4. WBC count:

    Normal value: 5,000-10,000/L

    Clinical significance:A. Increased

    1) acute or chronic infections

    2) trauma3) leukemia

    4) stress

    B. Decreased1) anemia

    2) viral infections

  • 8/6/2019 BLOOD 09-10

    21/44

    5. Platelet count

    Normal values: 150,000-300,000/L

    Clinical significance:

    A. Increased

    1) cancer

    2) trauma

    3) cirrhosis

    B. Decreased

    1) anemia

    2) allergic conditions

    3) hemorrhage

  • 8/6/2019 BLOOD 09-10

    22/44

    6. Differential (WBC) Count

    WBC Type andNormal Percentage

    1. neutrophils60-70%2. eosinophils

    2-4%3. basophils

    0.5-1%4. lymphocytes

    20-25%5. monocytes

    3-8%

  • 8/6/2019 BLOOD 09-10

    23/44

  • 8/6/2019 BLOOD 09-10

    24/44

  • 8/6/2019 BLOOD 09-10

    25/44

  • 8/6/2019 BLOOD 09-10

    26/44

  • 8/6/2019 BLOOD 09-10

    27/44

    Red Blood Cells (RBC)-erythrocytosis or polycythemia-anemia / erythroblastopenia

    White Blood Cells (WBC):leukocytosis - leukopenia

    Lymphocytes: lymphocytosis -- lymphocytopenia granulocytes: granulocytosis -- granulocytopenia

    / agranulocytosis Neutrophils: neutrophilia -- neutropenia Eosinophils: eosinophilia -- eosinopenia Basophils: basophilia -- basopenia

    Platelets: thrombocytosis -- thrombocytopenia

    All cell lines - pancytopenia

    Type of Cell Increase Decrease

  • 8/6/2019 BLOOD 09-10

    28/44

    BLOOD TYPING

    (ABO TYPING and Rh TYPING)

  • 8/6/2019 BLOOD 09-10

    29/44

  • 8/6/2019 BLOOD 09-10

    30/44

  • 8/6/2019 BLOOD 09-10

    31/44

  • 8/6/2019 BLOOD 09-10

    32/44

  • 8/6/2019 BLOOD 09-10

    33/44

  • 8/6/2019 BLOOD 09-10

    34/44

    Hemolytic Disease of theNewborn (HDN)

    (Erythroblastosis fetalis)

  • 8/6/2019 BLOOD 09-10

    35/44

    RhT

    YPI

    NG

    ERYTHROBLASTOSIs

    F

    ETA

    LIs

  • 8/6/2019 BLOOD 09-10

    36/44

  • 8/6/2019 BLOOD 09-10

    37/44

    Benefits of Amniocentesis

    I h i f h Rh T i

  • 8/6/2019 BLOOD 09-10

    38/44

    Inheritance of the Rh Trait

  • 8/6/2019 BLOOD 09-10

    39/44

    Complications of HDN anemia (in some cases, the anemia is

    severe with enlargement of the liverand spleen)

    jaundice - yellowing of the skin, eyes,

    and mucous membranes. hydrops fetalis - heart failure and large

    amounts of fluid build up in the fetaltissues and organs (see figure)

    After birth, the red blood celldestruction may continue. Problemsmay include the following:a) severe jaundice

    b) enlarged liverc) anemiad) kernicterus - too much bilirubin in

    the brain causing seizures, brain

    damage, deafness, and death.

  • 8/6/2019 BLOOD 09-10

    40/44

    Symptoms of Rh disease Mother no physical signs of Rh disease

    Fetus:

    Amniocentesis - the amniotic fluid may have a yellow

    coloring and contain bilirubin. Ultrasound of the fetus - enlarged liver, spleen, or

    heart and fluid build up in the fetus' abdomen.

    The symptoms of Rh disease may resemble otherconditions or medical problems.

    Always consult your physician for a diagnosis.

  • 8/6/2019 BLOOD 09-10

    41/44

    Diagnosis of the Rh Disease Blood testing of both parents (Rh negativemother, Rh positive father).

    Diagnosis of previous pregnancy via:

    complete medical history and physical examination,

    diagnostic procedures for Rh disease : presence of Rh positive antibodies in the mother's blood

    ultrasound of fetus.

    amniocentesis - measure the amount of bilirubin in theamniotic fluid.

    sampling of some of the blood from the fetal umbilical cordduring pregnancy - checks for antibodies, bilirubin, andanemia in the fetus.

  • 8/6/2019 BLOOD 09-10

    42/44

    Treatments for Rh disease Intrauterine blood transfusion of red blood cells

    into the baby's circulation - a procedure that is performedby placing a needle through the mother's uterus and intothe abdominal cavity of the fetus or directly into the veinin the umbilical cord. It may be necessary to give asedative medication to keep the baby from moving.Intrauterine transfusions may need to be repeated.

    Early delivery, if the fetus develops complications (ifthe fetus has mature lungs, labor and delivery may beinduced to prevent worsening of the disease)

  • 8/6/2019 BLOOD 09-10

    43/44

    Prevention of Rh disease Administration of Rh immunoglobulin

    (RhIg), also known as RhoGAM.

    destroys any anti-Rh antibodies that enter themother's circulation before her immunesystem becomes sensitized; protection for a

    future Rh positive baby.

    given around the 28th week of pregnancy.

    after delivery, a woman should receive asecond dose of the drug within 72 hours.

  • 8/6/2019 BLOOD 09-10

    44/44

    The End